| 查看: 594 | 回复: 0 | |||
[交流]
新加坡国立大学药理学系博士后研究员
|
|
我们现在诚招新加坡国立大学医学院药理学系博士后研究员,研究课题为“rna疗法在白血病小鼠模型的研发”。我们学系的更多信息请参见: https://lelabnus.wordpress.com/ 职位任期为一年制合约。 you are invited to apply for a postdoctoral research fellow position working on “the development of a new rna therapy for leukemia treatment in mouse models” in the department of pharmacology, yong loo lin school of medicine. more information on the department is available at https://lelabnus.wordpress.com/. appointments will be made on a yearly contract basis. 研究员将负责在实验室负责人和其他团队成员合作下展开如下实验,细胞培养,小鼠实验和各类功能试验,以保证课题准时完成。研究员的主要工作职责还包括通用实验技术,如分子细胞实验,体内实验,数据采集,数据分析,文章撰写和汇报。 purpose of the post: the research fellow (rf) will be responsible to conduct research on cell culture, mouse experiments and various functional assays, and work closely with, the principal investigator and study team members to ensure the successful completion of the project on time. the rf’s principal role will be to work in general practices such as molecular cell experiments, in vivo experiments, data collection, data analysis, manuscript writing and presentations. 资质:申请人应: (a) 持有分子细胞生物学或相关专业的博士学位;英文流利; (b) 有能力独立和在团队中合作,有探索精神,注重细节;和 (c) 在人源细胞培养和小鼠模型体内实验领域经验丰富(并在知名期刊上发表至少一篇一作文章) 薪资将与候选人的资质和经验相匹配。若感兴趣,联系黎月明博士(phcltnm@nus.edu.sg)并附上个人简历。 qualifications: the applicant should: (a) have a ph.d. degree in molecular cell biology or related disciplines; with fluent english (b) be able to work independently and in a team, have an investigative nature, attention to detail; and (c) have a strong experience in research especially with human cell culture and in vivo experiments in mouse models (at least one first-author publication in a good journal) remuneration will be commensurate with the candidate’s qualifications and experience. if you are interested, please contact dr. minh le (phcltnm@nus.edu.sg) with your cv. |
» 猜你喜欢
拟解决的关键科学问题还要不要写
已经有11人回复
救命帖
已经有5人回复
限项规定
已经有5人回复
为什么nbs上溴 没有产物点出现呢
已经有9人回复
招博士
已经有3人回复
存款400万可以在学校里躺平吗
已经有35人回复
最失望的一年
已经有18人回复
求推荐博导
已经有4人回复
求推荐英文EI期刊
已经有5人回复
疑惑?
已经有5人回复













回复此楼